Journals / Gazi Medical Journal / 2011 / Cilt: 22 - Sayı: 4

Mitral kapak hastalığı nedeniyle mitral kapak replasmanı yapılan hastalarda diyabetes mellitusun erken morbiditeye etkisi

The effect of type II diabetes mellitus on early morbidity after mitral valve replacement for mitral valve disease

Pages
105–109
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study showed that DM not only increases short-term morbidity due to its multiple effects but is also an independent risk factor for surgical site infection, cerebrovascular disorder, arrhythmia and requirement of revision after isolated mitral valve replacement procedures. (Gazi Med J 2011; 22: 105-9)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The impact of DM on post-operative morbidity and mortality after valve surgery is less well defined and the results of the studies are controversial.
📊
Key Findings & Data:Methods: The study population included 214 consecutive patients undergoing isolated mitral valve replacement (MVR) with mechanical valves under cardiopulmonary bypass (CPB).
💡
Conclusion & Impact:Conclusion: This study showed that DM not only increases short-term morbidity due to its multiple effects but is also an independent risk factor for surgical site infection, cerebrovascular disorder, arrhythmia and requirement of revision after isolated mitral valve replacement procedures. (Gazi Med J 2011; 22: 105-9)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The impact of DM on post-operative morbidity and mortality after valve surgery is less well defined and the results of the studies are controversial. This study evaluated the effects of DM on post-operative short-term morbidity after isolated mitral valve replacement. Methods: The study population included 214 consecutive patients undergoing isolated mitral valve replacement (MVR) with mechanical valves under cardiopulmonary bypass (CPB). Patients were divided into two groups; diabetics (group I, n=36) and non-diabetics (group II, n=178). The groups were compared with respect to pre- and postoperative creatinine and blood urea nitrogen (BUN) levels, post-operative cerebrovascular disorders, arrhythmia, post-operative revision due to blood loss, surgical site infection, post-opertive extubation time, intensive care unit (ICU) and in-hospital stay time, CPB and aortic cross-clamp time. Results: In the diabetic group, post-operative rate of cerebrovascular disorders (13.9% vs. 2.8%; p=0.015), intubation time (11.5±7.6 h vs. 10.4±15.9 h; p=0.001), length of ICU stay (3.5±2.9 d vs. 2.7±2.1 d; p=0.001) and in-hospital stay (14.4±8.9 d vs. 11.1±6.9 d; p=0.023), rate of surgical site infection (19.4% vs. 3.9%; p=0.003), revision requirement rate (16.7% vs. 6.2%; p=0.045) were significantly higher. DM was also identified as an independent risk factor for surgical site infection, cerebrovascular disorder, arrhythmia and requirement of revision. Conclusion: This study showed that DM not only increases short-term morbidity due to its multiple effects but is also an independent risk factor for surgical site infection, cerebrovascular disorder, arrhythmia and requirement of revision after isolated mitral valve replacement procedures. (Gazi Med J 2011; 22: 105-9)

Özet

Amaç: Diyabetes mellitusun izole kalp kapağı operasyonları sonrası morbidite ve mortaliteye etkisi halen tam anlamıyla tanımlanamamıştır. Bizim çalışmamızın amacı da mitral kapak hastalığına bağlı izole mitral kapak replasmanı yapılan hastalarda diabetes mellitusun postoperatif erken morbidite üzerine olan etkisinin incelenmesidir. Yöntemler: 2000-2010 yılları arasında Hacettepe Üniversitesi Tıp Fakültesi Kalp ve Damar Cerrahisi Kliniğinde mitral kapak replasmanı yapılan 214 erişkin hasta retrospektif olarak incelenmiştir. DM tanısı olan 36 hasta grup Ii, DM tanısı olmayan 178 hasta da grup IIyi oluşturmuştur. Bulgular: Hastaların preoperatif özellikleri karşılaştırıldığında, serebrovasküler bozukluk, KOAH, aritmi ve renal fonksiyon bozukluğu açısından gruplar arasında farklılık saptanmadı. Ancak, preoperatif hipertansiyon öyküsü diabetik grupta istatistiksel olarak anlamlı olacak şekilde daha sık olarak görüldü. Preoperatif Ejeksiyon fraksiyon (EF) değeri de grup Ide grup IIye göre anlamlı biçimde düşük bulundu. Grup Ide postoperatif serebrovasküler bozukluk oranı, postoperatif entübasyon süresi, postoperatif yoğun bakımda ve hastanede kalış süresi, yara yeri enfeksiyonu oranı ve revizyon oranı istatistiksel olarak anlamlı düzeyde yüksek saptandı (sırasıyla p=0.015, p=0.01, p=0.01, p=0.023, p=0.003 ve p=0.045). Postoperatif aritmi oranı, postoperatif renal fonksiyon bozukluğu, KPB süresi, aort klemp süresi ve erken mortalite açısından gruplar arasında anlamlı farklılık görülmedi. Diabetin yara yeri enfeksiyonu oranını 5.9 kat (p=0.002), SVB oranını 5.6 kat (p=0.009), aritmi oranını 1.3 kat (p=0.497) ve revizyon oranını 3 kat (p=0.042) arttırdığı hesaplandı. Sonuç: Mitral kapak hastalığı nedeniyle MVR yapılan hastalarda DM birçok yönden risk faktörü oluşturarak erken dönem morbiditeyi olumsuz etkilemektedir. Kapak replasmanı planlanan ileri yaşlı ve ciddi risk profili içeren hastaların sayısının giderek arttığı da düşünüldüğünde DMnin bu etkisi cerrahi planlamada değerlendirmeye alınmalıdır. (Gazi Med J 2011; 22: 105-9)

🔖

Cite This Article

DEMİRCİN, M., DOĞAN, R., KUMBASAR, U., PAŞAOĞLU, İ., YILMAZ, M. (2022). Mitral kapak hastalığı nedeniyle mitral kapak replasmanı yapılan hastalarda diyabetes mellitusun erken morbiditeye etkisi. Gazi Medical Journal, Cilt: 22 - Sayı: 4, 105–109. https://ajindex.com/articles/520221

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Morris JJ, Smith LR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, et al. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation 1991; 84: 275-84
  2. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29: 334-9. [CrossRef] 3. General information and national estimates on diabetes in the United States. Atlanta, GA: Department of Health and Human Services and Centers for Disease Control and Prevention. 2005
  3. Kannel WB, McGe DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979; 59: 8-13
  4. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 2001; 24: 1614-9. [CrossRef] 6. Hoogwerf BJ, Waness A, Cressman M, Canner J, Campeau L, Domanski M, et al. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes 1999; 48: 1289-94. [CrossRef] 7. Salomon NW, Page US, Okies JE, Stephens J, Krause AH, Bigelow JC. Diabetes mellitus and coronary artery bypass. Short-term risk and longterm prognosis. J Thorac Cardiovasc Surg 1983; 85: 264-71
  5. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40: 418-23. [CrossRef] 9. Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 1045-52. [CrossRef] 10. Calafiore AM, Di Mauro M, Di Giammarco G, Contini M, Vitolla G, Iaco AL, et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 2003; 125: 144-54. [CrossRef] 11. Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Kerendi F, Song HK, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2008; 136: 631-40. [CrossRef] 12. Rajakaruna C, Rogers CA, Suranimala C, Angelini GD, Ascione R. The effect of diabetes mellitus on patients undergoing coronary su